Last reviewed · How we verify
Dermatosis of scalp
Approved treatments
- Temovate · Fougera Pharms
- Betamethasone Valerate · Fougera Pharms Inc
- Betametasone
Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Dermatosis of scalp patent landscape — cliff calendar, originator estates, attackable patents
- Dermatosis of scalp treatment landscape brief
- Dermatosis of scalp treatment updates RSS
Frequently asked questions about Dermatosis of scalp
What drugs treat Dermatosis of scalp?
Tracked treatments include Temovate, Betamethasone Valerate, Betametasone.
What is the treatment for Dermatosis of scalp?
Standard treatment for Dermatosis of scalp includes Temovate, Betamethasone Valerate, Betametasone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Dermatosis of scalp patent cliff · Dermatosis of scalp CI report
- Treatment: Temovate · Fougera Pharms
- Treatment: Betamethasone Valerate · Fougera Pharms Inc
- Treatment: Betametasone
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing